Neuropeptide Y prevents nucleus pulposus cells from cell apoptosis and IL‑1β‑induced extracellular matrix degradation

References

• Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. Clin Spine Surg. 2000;13:205–217.
   Google Scholar
• Peng B, Wu W, Hou S, et al. The pathogenesis of discogenic low back pain. J Bone Joint Surg Br Vol. 2005;87:62–67.
   PubMedGoogle Scholar
• Guo J, Shao M, Lu F, et al. Role of Sirt1 plays in nucleus pulposus cells and intervertebral disc degeneration. Spine (Phila Pa 1976). 2017;42(13):E757–E766. .
   PubMed Web of Science ®Google Scholar
• Roughley PJ. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine (Phila Pa 1976). 2004;29(23):2691–2699.
   PubMed Web of Science ®Google Scholar
• Dowdell J, Erwin M, Choma T, et al. Intervertebral disk degeneration and repair. Neurosurgery. 2017;80(3S):S46–S54. .
   PubMed Web of Science ®Google Scholar
• Sakai D, Grad S. Advancing the cellular and molecular therapy for intervertebral disc disease. Adv Drug Deliv Rev. 2015;84:159–171.
   PubMed Web of Science ®Google Scholar
• Gorth DJ, Shapiro IM, Risbud MV. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10:1–14.
   PubMed Web of Science ®Google Scholar
• Nakazawa KR, Walter BA, Laudier DM, et al. Accumulation and localization of macrophage phenotypes with human intervertebral disc degeneration. Spine J. 2018;18(2):343–356. .
   PubMed Web of Science ®Google Scholar
• Le Maitre CL, Hoyland JA, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile. Arthritis Res Ther. 2007;9(4):R77.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982;296(5858):659–660.
   PubMed Web of Science ®Google Scholar
• Li C, Wu X, Liu S, et al. Roles of neuropeptide Y in neurodegenerative and neuroimmune diseases. Front Neurosci. 2019;13:869. .
   PubMed Web of Science ®Google Scholar
• Amano S, Arai M, Goto S, et al. Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells. Biochim Biophys Acta. 2007;1770(6):966–973. .
   PubMed Web of Science ®Google Scholar
• Loh K, Herzog H, Shi Y-C. Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab. 2015;26(3):125–135.
   PubMed Web of Science ®Google Scholar
• Farzi A, Reichmann F, Holzer P. The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol. 2015;213(3):603–627.
   PubMed Web of Science ®Google Scholar
• Schwarz H, Villiger PM, Von Kempis J, et al. Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol. 1994;51(1):53–61. .
   PubMed Web of Science ®Google Scholar
• Mitić K, Stanojević S, Kuštrimović N, et al. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors. Peptides. 2011;32(8):1626–1633. .
   PubMed Web of Science ®Google Scholar
• De La Fuente M, Del Rıo M, Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol. 2001;116:156–167.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang L, Pan H, et al. Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis. BMC Musculoskelet Disord. 2014;15(1):319. .
   PubMedGoogle Scholar
• Brismée J-M, Sizer PS Jr, Dedrick GS, et al. Immunohistochemical and histological study of human uncovertebral joints: a preliminary investigation. Spine (Phila Pa 1976). 2009;34(12):1257–1263. .
   PubMed Web of Science ®Google Scholar
• Ahmed M, Bjurholm A, Kreicbergs A, et al. Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptideimmunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine (Phila Pa 1976). 1993;18:268–273.
   PubMed Web of Science ®Google Scholar
• Ashton IK, Roberts S, Jaffray DC, et al. Neuropeptides in the human intervertebral disc. J Orthop Res. 1994;12(2):186–192. .
   PubMed Web of Science ®Google Scholar
• Chen R, Hao Z, Chen X, et al. Neuropeptide Y enhances proliferation and chondrogenic differentiation of ATDC5 cells. Neuropeptides. 2020;80:102022.
   PubMed Web of Science ®Google Scholar
• Sowa GA, Perera S, Bechara B, et al. Associations between serum biomarkers and pain and pain-related function in older adults with low back pain: a pilot study. J Am Geriatr Soc. 2014;62(11):2047–2055. .
   PubMed Web of Science ®Google Scholar
• Schell E, Theorell T, Hasson D, et al. Stress biomarkers’ associations to pain in the neck, shoulder and back in healthy media workers: 12-month prospective follow-up. Eur Spine J. 2008;17:393–405.
   PubMed Web of Science ®Google Scholar
• Goode AP, Schwartz TA, Kraus VB, et al. Inflammatory, structural, and pain biochemical biomarkers may reflect radiographic disc space narrowing: the Johnston county osteoarthritis project. J Orthop Res. 2020;38(5):1027–1037. .
   PubMed Web of Science ®Google Scholar
• Chen F, Liu H, Li Z, et al. Paraoxonase 1 was negatively associated with intervertebral disc degeneration. Spine (Phila Pa 1976). 2019;44(18):E1053–E1062. .
   PubMed Web of Science ®Google Scholar
• Wang J, Chen H, Cao P, et al. Inflammatory cytokines induce caveolin‐1/β‐catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway. Cell Prolif. 2016;49:362–372.
   PubMed Web of Science ®Google Scholar
• Vergroesen -P-P, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 2015;23(7):1057–1070. .
   PubMed Web of Science ®Google Scholar
• Kedong H, Wang D, Sagaram M, et al. Anti-inflammatory effects of interleukin-4 on intervertebral disc cells. Spine J. 2020;20(1):60–68. .
   PubMed Web of Science ®Google Scholar
• Andrade P, Hoogland G, Garcia MA, et al. Elevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J. 2013;22(4):714–720. .
   PubMed Web of Science ®Google Scholar
• Weiler C, Nerlich AG, Bachmeier BE, et al. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976). 2005;30(1):44–53. .
   PubMed Web of Science ®Google Scholar
• Shamji MF, Setton LA, Jarvis W, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheumatism. 2010;62:1974–1982.
   PubMed Web of Science ®Google Scholar
• Johnson ZI, Schoepflin ZR, Choi H, et al. Disc in flames: roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater. 2015;30:104.
   PubMed Web of Science ®Google Scholar
• Kepler CK, Markova DZ, Hilibrand AS, et al. Substance P stimulates production of inflammatory cytokines in human disc cells. Spine (Phila Pa 1976). 2013;38(21):E1291–E1299. .
   PubMed Web of Science ®Google Scholar
• Kepler CK, Markova DZ, Koerner JD, et al. Substance P receptor antagonist suppresses inflammatory cytokine expression in human disc cells. Spine (Phila Pa 1976). 2015;40(16):1261–1269.
   PubMed Web of Science ®Google Scholar
• McCarthy P, Carruthers B, Martin D, et al. Immunohistochemical demonstration of sensory nerve fibers and endings in lumbar intervertebral discs of the rat. Spine (Phila Pa 1976). 1991;16(6):653–655. .
   PubMed Web of Science ®Google Scholar
• Oztas B, Sahin D, Kir H, et al. The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-alpha, Il-1beta, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model. Neuropeptides. 2017;61:31–37.
   PubMed Web of Science ®Google Scholar
• Ferreira R, Santos T, Viegas M, et al. Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells. J Neuroinflammation. 2011;8:169.
   PubMed Web of Science ®Google Scholar
• Zhou JR, Xu Z, Jiang CL. Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor. Neurosci Bull. 2008 Jun;24(3):155–1559.
   PubMedGoogle Scholar
• Dombrowski ME, Olsen AS, Vaudreuil N, et al. Rabbit annulus fibrosus cells express neuropeptide Y, which is influenced by mechanical and inflammatory stress. Neurospine. 2020;17(1):69–76. .
   PubMed Web of Science ®Google Scholar
• Wang W, Xu T, Chen X, et al. NPY receptor 2 mediates NPY antidepressant effect in the mPFC of LPS rat by suppressing NLRP3 signaling pathway. Mediators Inflamm. 2019;2019:7898095. .
   PubMed Web of Science ®Google Scholar
• Stadler J, Le TP, Haas P, et al. Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels. Ann Anat. 2011;193(6):486–493.
   PubMed Web of Science ®Google Scholar
• Diaz-delcastillo M, Woldbye DPD, Heegaard AM. Neuropeptide Y and its involvement in chronic pain. Neuroscience. 2018;387:162–169. .
   PubMed Web of Science ®Google Scholar
• Fu W, Nelson TS, Santos DF, et al. An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain. Pain. 2019;160(8):1754–1765. .
   PubMed Web of Science ®Google Scholar
• Han Y, Li X, Yan M, et al. Oxidative damage induces apoptosis and promotes calcification in disc cartilage endplate cell through ROS/MAPK/NF-κB pathway: implications for disc degeneration. Biochem Biophys Res Commun. 2019;516(3):1026–1032. .
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhang L, Zhang K, et al. Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein. Ann Rheum Dis. 2018;77(5):770–779. .
   PubMed Web of Science ®Google Scholar
• Zhao C-Q, Jiang L-S, Dai L-Y. Programmed cell death in intervertebral disc degeneration. Apoptosis. 2006;11(12):2079–2088.
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. science. 1998;281(5381):1309–1312.
   PubMed Web of Science ®Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
   PubMed Web of Science ®Google Scholar
• Coleman MC, Goetz JE, Brouillette MJ, et al. Targeting mitochondrial responses to intra-articular fracture to prevent posttraumatic osteoarthritis. Sci Transl Med. 2018;10(427):eaan5372. .
   PubMed Web of Science ®Google Scholar
• Hu Y, Shao Z, Cai X, et al. Mitochondrial pathway is involved in advanced glycation end products-induced apoptosis of rabbit annulus fibrosus cells. Spine (Phila Pa 1976). 2019;44(10):E585. .
   PubMed Web of Science ®Google Scholar
• Wu J, Liu S, Meng H, et al. Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/β-catenin pathway in vitro. Stem Cell Res. 2017;21:74–84.
   PubMed Web of Science ®Google Scholar
• Fatoba O, Kloster E, Reick C, et al. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington’s disease. Exp Neurol. 2018;302:112–128.
   PubMed Web of Science ®Google Scholar